Potential Side Effects From Venetoclax + Rituximab In CLL
Rod A. Humerickhouse, MD, PhD, Group Project Leader, Oncology Development, AbbVie, discusses Potential Side Effects From Venetoclax + Rituximab In CLL. At The 60th ASH Annual Meeting on Dec 1, 2018.
Author: obr
Added: 01/15/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Rituxan